NCT07504796 2026-04-01
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
NYU Langone Health
Phase 4 Not yet recruiting
Clinical Trials
8 trialsNCT06031233 2026-03-30
MINUTE
Isala
Phase 4 Recruiting
NCT07028125 2025-10-07
CANIQOL
Centre Francois Baclesse
Phase 4 Recruiting
NCT06934057 2025-09-24
CABOLD
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4 Recruiting
NCT02626065 2025-09-15
PAIR
Hospices Civils de Lyon
Phase 4 Completed
NCT06116461 2024-04-22
NIVOPTIMIZE
Erasmus Medical Center
Phase 4 Recruiting
NCT03313544 2023-04-21
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
Assistance Publique Hopitaux De Marseille
Phase 4 Unknown
NCT04707547 2021-01-13
RFA
Taipei Medical University WanFang Hospital
Phase 4 Completed